CN
Search Within
57-66-9
Applied Filters:
Keyword:'57-66-9'
Showing 31-45 of 45 results for "57-66-9" within Papers
Karran A Phillips et al.
Addictive behaviors, 38(10), 2485-2491 (2013-06-19)
Real-time monitoring of behavior using Ecological Momentary Assessment (EMA) has provided detailed data about daily temporal patterns of craving and use in cigarette smokers. We have collected similar data from a sample of cocaine and heroin users. Here we analyzed
Nuno Sérgio Dias et al.
Medical engineering & physics, 34(7), 972-981 (2011-12-14)
This paper presents a complete non-invasive Wireless acquisition system based on dry electrodes for electroencephalograms (WiDE-EEG) with emphasis in the electronic system design. The WiDE-EEG is composed by a 2.4 GHz radio-frequency (RF) transceiver, biopotential acquisition electronics and dry electrodes.
Evan C Frary et al.
Medicine, 96(30), e7613-e7613 (2017-07-27)
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of autoimmune diseases characterized by systemic inflammation in small- to medium-sized blood vessels. Although immunosuppressive therapy has greatly improved the prognosis for these patients, there are still significant comorbidities, such as
A S Ryan et al.
Diabetes care, 24(9), 1646-1652 (2001-08-28)
The ACE insertion/deletion (I/D) polymorphism has been identified as a genetic risk factor for coronary heart disease (CHD). The deletion (D) allele of the ACE gene may be associated with higher insulin sensitivity. Individuals who are homozygous for the DD
Larry D Lawson et al.
Nutrients, 10(7) (2018-06-26)
Allicin is considered responsible for most of the pharmacological activity of crushed raw garlic cloves. However, when garlic supplements and garlic foods are consumed, allicin bioavailability or bioequivalence (ABB) has been unknown and in question because allicin formation from alliin
M J Taverna et al.
Diabetologia, 45(3), 436-442 (2002-03-27)
Vitamin D, a molecule with antiproliferative, antiangiogenic, antioxidant and immunosuppressive effects, could play a role in the pathogenesis of severe diabetic retinopathy. We examined whether Taq I polymorphism of the vitamin D receptor is involved in the development of severe
Claudia Trenkwalder et al.
The Lancet. Neurology, 12(12), 1141-1150 (2013-10-22)
Opioids are a potential new treatment for severe restless legs syndrome. We investigated the efficacy and safety of a fixed-dose combination of prolonged release oxycodone-naloxone for patients with severe restless legs syndrome inadequately controlled by previous, mainly dopaminergic, treatment. This
Julia Turbiner Geyer et al.
The American journal of surgical pathology, 33(8), 1157-1163 (2009-06-23)
It has been recently suggested that ovarian serous carcinoma follows a dualistic pathway with low-grade carcinomas arising from borderline tumors and high-grade carcinomas originating de novo. Similarly, our group has shown that based on their molecular profile endometrioid borderline tumors
R G Miller et al.
The Cochrane database of systematic reviews, (1)(1), CD001447-CD001447 (2007-01-27)
Riluzole has been approved for treatment of patients with amyotrophic lateral sclerosis in most countries. Questions persist about its clinical utility because of high cost and modest efficacy. To examine the efficacy of riluzole in prolonging survival, and in delaying
Karen M Edmond et al.
Lancet (London, England), 385(9975), 1315-1323 (2014-12-17)
Results of randomised controlled trials of newborn (age 1-3 days) vitamin A supplementation have been inconclusive. The WHO is coordinating three large randomised trials in Ghana, India, and Tanzania (Neovita trials). We present the findings of the Neovita trial in
R G Miller et al.
The Cochrane database of systematic reviews, (2)(2), CD001447-CD001447 (2002-06-22)
Riluzole has been approved for treatment of patients with amyotrophic lateral sclerosis in many countries but not all. Questions persist about its clinical utility because of high cost, modest efficacy and concern over adverse effects. To examine the efficacy of
Bradley J Monk et al.
The Lancet. Oncology, 15(8), 799-808 (2014-06-22)
Angiogenesis is a valid target in the treatment of epithelial ovarian cancer. Trebananib inhibits the binding of angiopoietins 1 and 2 to the Tie2 receptor, and thereby inhibits angiogenesis. We aimed to assess whether the addition of trebananib to single-agent
Catherine K Chang et al.
Journal of vascular surgery, 60(6), 1554-1564 (2014-07-22)
Despite poor long-term patency, acceptable limb salvage has been reported with cryopreserved saphenous vein bypass (CVB) for various indications. However, utility of CVB in patients with critical limb ischemia (CLI) remains undefined. The purpose of this analysis was to determine
R G Miller et al.
Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases, 4(3), 191-206 (2003-09-18)
Riluzole 100 mg probably prolongs survival in patients with amyotrophic lateral sclerosis by about two months and the safety of the drug is not a major concern. The evidence from randomized controlled trials indicates that patients taking riluzole probably survive
Rosario Pivonello et al.
The lancet. Diabetes & endocrinology, 8(9), 748-761 (2020-07-31)
Cushing's disease is a rare endocrine disorder characterised by cortisol overproduction with severe complications. Therapies for cortisol reduction are often necessary. Here we report the outcomes from the pivotal phase III study of osilodrostat (a potent oral inhibitor of cytochrome
Page 2 of 2